Edgewise Therapeutics stockEWTX
Edgewise Therapeutics trades at $38.87, 19.9% below its 52-week high (Sep 17, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +56.6% year to date, +123.8% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.
Ratings, candles, signals and the screener for EWTX — after you log in
Open the terminalFrequently asked questions about Edgewise Therapeutics
What is the Edgewise Therapeutics stock price?
At the close on Nov 5, 2026: $38.87 (+3.57% on the day). 52-week high: $48.51 on Sep 17, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Edgewise Therapeutics report earnings?
The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed +2,574% year over year, revenue 0%.
Does Edgewise Therapeutics pay dividends?
No, Edgewise Therapeutics does not pay dividends.
Where does Edgewise Therapeutics trade and how to buy it?
Ticker EWTX, exchange Nasdaq, listed since 2021. You can buy it through a broker with access to US exchanges.
Should I buy Edgewise Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for EWTX are in the terminal after you log in.